A heterotrimeric serine-threonine kinase, AMPK, functions as a key cellular energy sensor in most tissues, and a potential therapeutic target for the prevention and/or treatment of NAFLD by many natural compounds [26]. Here, MARK2 is linked to metabolic dysfunction-associated steatotic liver disease.